Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -462.00K | 5.41M | 14.15M | -431.00K | -7.84M |
| Total Depreciation and Amortization | -6.00K | 14.00K | 20.00K | 23.00K | 40.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -158.00K | -153.00K | 1.09M | 405.00K | 404.00K |
| Change in Net Operating Assets | 3.05M | -2.91M | -20.35M | -3.38M | 2.45M |
| Cash from Operations | 2.42M | 2.36M | -5.09M | -3.38M | -4.95M |
| Capital Expenditure | -- | -- | -2.00K | 2.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -14.00K | 14.00K | -1.00K | 1.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.20M | -1.02M | 7.31M | 2.48M | -14.26M |
| Cash from Investing | 16.19M | -1.00M | 7.31M | 2.48M | -14.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 59.00K | -- | 0.00 | 0.00 | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -247.00K | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -25.13M | -- | -- | -- | -- |
| Cash from Financing | -25.32M | -- | 0.00 | 0.00 | 1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.71M | 1.35M | 2.22M | -905.00K | -19.21M |